Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells

Keywords

Computer science

References

• The Human UTY Gene Encodes a Novel HLA-B8-Restricted H-Y Antigen1Edus H. Warren, Marc A. Gavin, Elizabeth Simpson — 2000
• Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.H-J Kolb, J. Mittermüller, Ch. Clemm — 1990
• Myeloid LeukemiaHarry Iland, Mark Hertzberg, Paula Marlton — 2020
• Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real‐time quantitative RT‐PCRMenskin, Van De Locht, Schattenberg — 1998
• UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition.Mario H. J. Vogt, Els Goulmy, Freke M. Kloosterboer — 2000
• Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.Marleen de Bueger, A Bakker, J. J. van Rood — 1992
• Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.HJ Kolb, A Schattenberg, JM Goldman — 1995
• Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.Robert H. Collins, Ofer Shpilberg, William R. Drobyski — 1997
• Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.Tuna Mutis, Robert M. Verdijk, Ellen Schrama — 1999
• Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominanceCécile A. C. M. van, J. D‘Amaro, J. Pool — 2004
• Cellular therapy: donor lymphocyte infusionKarl S. Peggs, Stephen Mackinnon — 2001
• Functional expression of minor histocompatibility antigens on human peripheral blood dendritic cells and epidermal Langerhans cells.Ellen van Lochem, Maarten van der Keur, A. Mieke Mommaas — 1996
• Adoptive immunotherapy with donor lymphocyte transfusions.Hans‐Jochem Kolb, Ernst Holler — 1997
• The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition.Leslie Meadows, Wei Wang, Joke M. M. den Haan — 1997
• Human T-cell receptor variable gene segment familiesBernhard Arden, StephenP. Clark, Dieter Kabelitz — 1995
• T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.Willem M. Smit, Marion Rijnbeek, Cornelis A.M. van Bergen — 1998
• Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein.Wei Wang, Leslie Meadows, Joke M. M. den Haan — 1995
• The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.Mario H. J. Vogt, Joost W. van den Muijsenberg, Els Goulmy — 2002
• Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants.Aloïs Gratwohl, J. Hermans, D Niederwieser — 2001
• Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies.Martina Wilke, Harry Dolstra, Frans Maas — 2003

Cited by

• Designing T-cells with desired T-cell receptor make-up for immunotherapyMarleen M. van Loenen — 2011
• Vakzinierungsversuche zur Leukämietherapie bei Patienten mit chronischer myeloischer Leukämie nach allogener StammzelltransplantationAdriane Koppelle — 2010
• Allogeneic cellular immunotherapy for chronic B-cell leukemiaMels Hoogendoorn — 2007
• Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemiaMhairi Copland, Alasdair R. Fraser, Simon J. Harrison — 2005
• Minor histocompatibility antigen DDX3Y induces HLA-DQ5-restricted T cell responses with limited TCR-Vbeta usage both in vivo and in vitro.David Laurin, Eric Spierings, Lars T. van der Veken — 2006
• Nonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation.Barry Flutter, Noha Edwards, Farnaz Fallah‐Arani — 2010
• Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantationMarie Bleakley, Cameron J. Turtle, Stanley R. Riddell — 2012
• Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.Anita N. Stumpf, Edith D. van der Meijden, Cornelis A.M. van Bergen — 2009
• A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cellsMarleen M. van Loenen, Renate de Boer, Ellis van Liempt — 2014
• Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: a survey of different populations.Simona Di Terlizzi, Elisabetta Zino, Benedetta Mazzi — 2006
• Effective graft depletion of MiHAg T-cell specificities and consequences for graft-versus-host disease.Moniek A. de Witte, Mireille Toebes, Ji‐Ying Song — 2007
• Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cellsPeter A. von dem Borne, Simone A.P. van Luxemburg-Heijs, Mirjam H.M. Heemskerk — 2006
• Allo-HLA-reactive T cells inducing graft-versus-host disease are single peptide specific.Avital L. Amir, Dirk M. van der Steen, Renate S. Hagedoorn — 2011
• Minor histocompatibility antigens in allogeneic hematopoietic cell transplantationEdus H. Warren — 2006
• Update on cancer vaccinesFreda K. Stevenson — 2005
• HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemiaCaroline E. Rutten, Simone A.P. van Luxemburg-Heijs, Marieke Griffioen — 2008
• The relevance of minor histocompatibility antigens in solid organ transplantationMiranda P. Dierselhuis, Els Goulmy — 2009
• Can immunotherapy specifically target acute myeloid leukemic stem cells?Sylvia Snauwaert, Bart Vandekerckhove, Tessa Kerre — 2013
• Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?Ben Sprangers — 2007
• Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation.Ann Mullally, Jerome Ritz — 2007

Related papers

No related papers recorded.